The integration of patient care and clinical research has been a hallmark of the MGH Department of Psychiatry for more than 30 years. Today, the department has the largest clinical research program in the hospital, with studies at the forefront of neuroscience, molecular biology and genetics.Breakthroughs and Innovations: Research at MGH Psychiatry.
The Mass General Department of Psychiatry’s wide-ranging research portfolio spans clinical and basic research on virtually every major psychiatric disorder. These initiatives typically began as clinical trials conducted in clinical units and expanded to observational and mechanistic studies with notable expansions in genetics, neuroimaging and basic neuroscience. This model of cross-talk between clinical care and science has consistently led to research advances.
Learn more about research at MGH Psychiatry HERE.
Adjunctive cariprazine improved both depressive and anxiety symptoms in patients with MDD, offering a promising strategy for treating residual anxiety that often persists despite antidepressants.
Read More
Despite the significant morbidity associated with catatonic symptoms, catatonia remains underrecognized and understudied, especially in children.
Read More
Machine learning models using EHR data significantly improved clinicians’ suicide risk assessments, offering more accurate predictions of future suicide attempts.
Read More
These pioneers in their fields represent the most influential researchers who have published multiple papers frequently cited by their peers that rank in the top 1% of citations in their fields.
Read More
This generous award will support research to identify and target suicide circuits in the brain, an approach that could lead to more individualized and effective treatments for suicidal ideation across various psychiatric disorders.
Sending our best wishes and strategies for managing stress and taking care of yourself from the Benson-Henry Institute of Mind Body Medicine, the Clay Center for Young Healthy Minds, and the Family Dinner Project.
This is a tremendous honor for the Department of Psychiatry, as it reflects how we are viewed by our peers and colleagues in the field.
Jennifer Thomas, PhD discusses recent research on ARFID, revealing distinct risk factors and neurobiological drivers that demand tailored clinical approaches.
From the clinicians and researchers in our department, a list of our most recent publications.
